全球基因組學服務市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

基因組學服務市場預計將從 2025 年的 100.6 億美元成長到 2034 年的 271.4 億美元，2026 年至 2034 年的複合年成長率為 11.66%。

由於基因組技術在醫療保健、生物技術和研究領域的應用日益廣泛，全球基因組學服務市場正經歷快速成長。基因組學服務包括DNA定序、基因表現分析、生物資訊服務和基因檢測。這些服務廣泛應用於疾病診斷、個人化醫療、藥物研發和農業研究。精準醫療的日益普及是推動基因組學服務市場擴張的主要因素。

定序技術的進步和基因組分析成本的降低是推動市場成長的關鍵因素。研究人員和醫療保健專業人員擴大利用基因組數據來了解疾病機制並開發標靶治療。此外，生物技術研發投入的增加以及政府對基因組研究的支持，正在加速基因組服務在全球的普及。

隨著基因組技術在臨床和研究應用中日益普及，基因組服務市場預計將會擴張。先進生物資訊學工具和高通量定序平台的開發將提升數據分析能力。此外，對個人化醫療和疾病早期檢測日益成長的需求也將繼續推動全球基因組服務的應用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球基因體學服務市場：依服務類型分類

• 市場分析、洞察與預測
• 次世代定序
• 基因型鑒定
• 微陣列
• 桑格定序
• 其他服務

第5章：全球基因體學服務市場：依應用分類

• 市場分析、洞察與預測
• 調查
• 診斷

第6章 全球基因組學服務市場：依最終用途分類

• 市場分析、洞察與預測
• 研究機構
• 診斷中心
• 製藥和生物技術公司
• 受託研究機構（CRO）
• 其他最終用途

第7章 全球基因體學服務市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • 23andMe
  • Agilent Technologies
  • BGI Genomics
  • Bio Rad Laboratories
  • Color Genomics
  • Danaher
  • Eurofins Scientific
  • F. Hoffmann-La Roche
  • GE Healthcare
  • GENEWIZ（Azenta）
  • Illumina
  • LGC
  • Macrogen
  • IQVIA
  • QIAGEN

The Genomics Services Market size is expected to reach USD 27.14 Billion in 2034 from USD 10.06 Billion (2025) growing at a CAGR of 11.66% during 2026-2034.

The global genomics services market is experiencing rapid growth due to increasing applications of genomic technologies in healthcare, biotechnology, and research. Genomics services include DNA sequencing, gene expression analysis, bioinformatics services, and genetic testing. These services are widely used in disease diagnosis, personalized medicine, drug discovery, and agricultural research. The growing focus on precision medicine is significantly contributing to the expansion of the genomics services market.

Advancements in sequencing technologies and decreasing costs of genomic analysis are major drivers supporting market growth. Researchers and healthcare providers are increasingly using genomic data to understand disease mechanisms and develop targeted therapies. Additionally, increasing investments in biotechnology research and government support for genomic studies are accelerating the adoption of genomics services globally.

Looking forward, the genomics services market is expected to expand as genomic technologies become more integrated into clinical and research applications. The development of advanced bioinformatics tools and high-throughput sequencing platforms will enhance data analysis capabilities. Furthermore, the growing demand for personalized healthcare and early disease detection will continue to drive the adoption of genomics services worldwide.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Service Type

• Next Generation Sequencing
• Genotyping
• Microarray
• Sanger Sequencing
• Other Services

By Application

• Research
• Diagnostics

By End Use

• Research Institutes
• Diagnostic Centers
• Pharmaceutical and Biotechnological Companies
• Contract Research Organizations (CROs)
• Other End Use

COMPANIES PROFILED

• 23andMe, Agilent Technologies, BGI Genomics, Bio Rad Laboratories, Color Genomics, Danaher, Eurofins Scientific, F HoffmannLa Roche, GE Healthcare, GENEWIZ Azenta, Illumina, LGC, Macrogen, IQVIA, QIAGEN
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GENOMICS SERVICES MARKET: BY SERVICE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Service Type
• 4.2. Next Generation Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Genotyping Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Microarray Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Sanger Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GENOMICS SERVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GENOMICS SERVICES MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Pharmaceutical and Biotechnological Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Contract Research Organizations (CROs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Other End Use Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GENOMICS SERVICES MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Service Type
  • 7.2.2 By Application
  • 7.2.3 By End Use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Service Type
  • 7.3.2 By Application
  • 7.3.3 By End Use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Service Type
  • 7.4.2 By Application
  • 7.4.3 By End Use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Service Type
  • 7.5.2 By Application
  • 7.5.3 By End Use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Service Type
  • 7.6.2 By Application
  • 7.6.3 By End Use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL GENOMICS SERVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 23andMe
  • 9.2.2 Agilent Technologies
  • 9.2.3 BGI Genomics
  • 9.2.4 Bio Rad Laboratories
  • 9.2.5 Color Genomics
  • 9.2.6 Danaher
  • 9.2.7 Eurofins Scientific
  • 9.2.8 F. Hoffmann-La Roche
  • 9.2.9 GE Healthcare
  • 9.2.10 GENEWIZ (Azenta)
  • 9.2.11 Illumina
  • 9.2.12 LGC
  • 9.2.13 Macrogen
  • 9.2.14 IQVIA
  • 9.2.15 QIAGEN